Lv3
362 积分 2024-03-13 加入
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
1天前
待确认
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
1天前
已完结
Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review
1天前
待确认
Permeability-Enhancing and Protective Effect on Small Intestine of Punicic Acid in Different Forms and Their Nanoemulsions With Low Toxicity
26天前
已完结
Boosting the oral absorption of insulin using Ultrafine bubbles
1个月前
已完结
Understanding the release mechanisms and secretion patterns for glucagon-like peptide-1 using the isolated perfused intestine as a model
1个月前
已完结
Chitosan hydrochloride coated and nonionic surfactant modified niosomes: a better way for oral administration of semaglutide
1个月前
已完结
Design of Auto-Adaptive Drug Delivery System for Effective Delivery of Peptide Drugs to Overcoming Mucus and Epithelial Barriers
1个月前
已完结
Rat intestinal drug permeability:A status report and summary of repeated determinations
1个月前
已完结
Intestinal Permeation Enhancers for Oral Deliveryof Macromolecules: A Comparison betweenSalcaprozate Sodium (SNAC) and SodiumCaprate (C10)
1个月前
已完结
皖公网安备34019202002308
